Paper33949293
Down-regulation of microRNA-125b-2-3p is a risk factor for a poor prognosis in hepatocellular carcinoma.
Huang HQ and 9 others. Bioengineered, 2021. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Down-regulation of microRNA-125b-2-3p is a risk factor for a poor prognosis in hepatocellular carcinoma. Papers, record 33949293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33949293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Down-regulation of microRNA-125b-2-3p is a risk factor for a poor prognosis in hepatocellular carcinoma.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Down-Regulation | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Liver Neoplasms | Major topic |
| MicroRNAs | Major topic |
| Female | |
| Gene Expression Profiling | |
| Humans | |
| Male | |
| Prognosis | |
| ROC Curve | |
| Risk Factors |
Source PubMed
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31934299 | Exploration and validation of downregulated microRNA-199a-3p, downstream messenger RNA targets and transcriptional regulation in osteosarcoma. | Am J Transl Res | 2019 | https://conductscience.org/library/papers/31934299 | PubMed |
| 2 | 31612005 | HDGF and PRKCA upregulation is associated with a poor prognosis in patients with lung adenocarcinoma. | Oncol Lett | 2019 | https://conductscience.org/library/papers/31612005 | PubMed |
| 3 | 25613900 | Proteomics. Tissue-based map of the human proteome. | Science | 2015 | https://conductscience.org/library/papers/25613900 | PubMed |
| 4 | 31730902 | LncRNA ID2-AS1 suppresses tumor metastasis by activating the HDAC8/ID2 pathway in hepatocellular carcinoma. | Cancer Lett | 2020 | https://conductscience.org/library/papers/31730902 | PubMed |
| 5 | 32366840 | Oncogenic driver genes and tumor microenvironment determine the type of liver cancer. | Cell Death Dis | 2020 | https://conductscience.org/library/papers/32366840 | PubMed |
| 6 | 31814271 | Nanoparticle Conjugation of Ginsenoside Rg3 Inhibits Hepatocellular Carcinoma Development and Metastasis. | Small | 2020 | https://conductscience.org/library/papers/31814271 | PubMed |
| 7 | 33188512 | Current perspectives on the tumor microenvironment in hepatocellular carcinoma. | Hepatol Int | 2020 | https://conductscience.org/library/papers/33188512 | PubMed |
| 8 | 31934297 | Identifying TF-miRNA-mRNA regulatory modules in nitidine chloride treated HCC xenograft of nude mice. | Am J Transl Res | 2019 | https://conductscience.org/library/papers/31934297 | PubMed |
| 9 | 33433946 | Cancer Statistics, 2021. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33433946 | PubMed |
| 10 | 26808342 | Cancer statistics in China, 2015. | CA Cancer J Clin | 2016 | https://conductscience.org/library/papers/26808342 | PubMed |
| 11 | 30718452 | miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/30718452 | PubMed |
| 12 | 30364632 | Coordinative control of G2/M phase of the cell cycle by non-coding RNAs in hepatocellular carcinoma. | PeerJ | 2018 | https://conductscience.org/library/papers/30364632 | PubMed |
| 13 | 31168049 | Overexpression of zinc finger protein 384 (ZNF 384), a poor prognostic predictor, promotes cell growth by upregulating the expression of Cyclin D1 in Hepatocellular carcinoma. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/31168049 | PubMed |
| 14 | 30007991 | Investigation of miR-490-3p Expression in Hepatocellular Carcinoma Based on Reverse Transcription-Polymerase Chain Reaction (RT-qPCR) and a Meta-Analysis of 749 Cases. | Med Sci Monit | 2018 | https://conductscience.org/library/papers/30007991 | PubMed |
| 15 | 31819482 | MIR22HG As A Tumor Suppressive lncRNA In HCC: A Comprehensive Analysis Integrating RT-qPCR, mRNA-Seq, And Microarrays. | Onco Targets Ther | 2019 | https://conductscience.org/library/papers/31819482 | PubMed |
| 16 | 31281357 | A Comprehensive Evaluation of the Association between Polymorphisms in XRCC1, ERCC2, and XRCC3 and Prognosis in Hepatocellular Carcinoma: A Meta-Analysis. | J Oncol | 2019 | https://conductscience.org/library/papers/31281357 | PubMed |
| 17 | 28402280 | Clinical significance of the correlation between PLCE 1 and PRKCA in esophageal inflammation and esophageal carcinoma. | Oncotarget | 2017 | https://conductscience.org/library/papers/28402280 | PubMed |
| 18 | 30832674 | Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data. | Respir Res | 2019 | https://conductscience.org/library/papers/30832674 | PubMed |
| 19 | 26226356 | miRWalk2.0: a comprehensive atlas of microRNA-target interactions. | Nat Methods | 2015 | https://conductscience.org/library/papers/26226356 | PubMed |
| 20 | 32931665 | The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues. | Cancer Med | 2020 | https://conductscience.org/library/papers/32931665 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42326330 | Alkaloids mediated regulation of microRNA in cancer: molecular insights and emerging therapeutic strategies. | Front Oncol | 2026 | https://conductscience.org/library/papers/42326330 | PubMed |
| 40626007 | Hsa_circ_0018909 promotes non-small cell lung cancer by directly regulating hsa-miR-513b-5p. | Front Oncol | 2025 | https://conductscience.org/library/papers/40626007 | PubMed |
| 39764737 | The miRNA-mRNA Regulatory Network in Human Hepatocellular Carcinoma by Transcriptomic Analysis From GEO. | Cancer Rep (Hoboken) | 2025 | https://conductscience.org/library/papers/39764737 | PubMed |
| 38976685 | The expression of MIR125B transcripts and bone phenotypes in Mir125b2-deficient mice. | PLoS One | 2024 | https://conductscience.org/library/papers/38976685 | PubMed |
| 38139235 | Plasma microRNA Profiling in Type 2 Diabetes Mellitus: A Pilot Study. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38139235 | PubMed |
| 36914902 | Nitidine chloride regulates cell function of bladder cancer in vitro through downregulating Lymphocyte antigen 75. | Naunyn Schmiedebergs Arch Pharmacol | 2023 | https://conductscience.org/library/papers/36914902 | PubMed |
| 36118845 | The diagnostic and prognostic value of the miR-17-92 cluster in hepatocellular carcinoma: A meta-analysis. | Front Genet | 2022 | https://conductscience.org/library/papers/36118845 | PubMed |
| 35628654 | The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Doxorubicin and Topotecan Resistant Ovarian Cancer Cell Lines. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35628654 | PubMed |
| 35443866 | MiR-4733-5p promotes gallbladder carcinoma progression via directly targeting kruppel like factor 7. | Bioengineered | 2022 | https://conductscience.org/library/papers/35443866 | PubMed |
| 34608826 | Upregulation of microRNA miR-652-3p is a prognostic risk factor for hepatocellular carcinoma and regulates cell proliferation, migration, and invasion. | Bioengineered | 2021 | https://conductscience.org/library/papers/34608826 | PubMed |
| 34516334 | MicroRNA miR-495 regulates the development of Hepatocellular Carcinoma by targeting C1q/tumor necrosis factor-related protein-3 (CTRP3). | Bioengineered | 2021 | https://conductscience.org/library/papers/34516334 | PubMed |
| 34346845 | Long non-coding RNA MCM3AP antisense RNA 1 promotes non-small cell lung cancer progression through targeting microRNA-195-5p. | Bioengineered | 2021 | https://conductscience.org/library/papers/34346845 | PubMed |
| 34180758 | Upregulation of microRNA miR-141-3p and its prospective targets in endometrial carcinoma: a comprehensive study. | Bioengineered | 2021 | https://conductscience.org/library/papers/34180758 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| DNAJB1 | 3337 | PubTator's text mining | https://conductscience.org/library/genes/3337 | NCBI Gene |
| ELAVL2 | 1993 | PubTator's text mining | https://conductscience.org/library/genes/1993 | NCBI Gene |
| MIR125B1 | 406911 | PubTator's text mining | https://conductscience.org/library/genes/406911 | NCBI Gene |
| MIR125B2 | 406912 | PubTator's text mining | https://conductscience.org/library/genes/406912 | NCBI Gene |
| PRKCA | 5578 | PubTator's text mining | https://conductscience.org/library/genes/5578 | NCBI Gene |
| RNU6-6P | 26826 | PubTator's text mining | https://conductscience.org/library/genes/26826 | NCBI Gene |
| SNORD48 | 26801 | PubTator's text mining | https://conductscience.org/library/genes/26801 | NCBI Gene |
| TENM1 | 10178 | PubTator's text mining | https://conductscience.org/library/genes/10178 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33949293
GET https://conductscience.org/api/papers/v1/33949293/references?page=2